Adoption and uptake of the lateral flow urine LAM test in countries with high tuberculosis and HIV/AIDS burden: current landscape and barriers

Background: Since 2015, the World Health Organization (WHO) has recommended a commercially available lateral-flow urine LAM test (Alere-LAM) to assist in the diagnosis of tuberculosis (TB) in severely ill people living with HIV (PLHIV). The test can rapidly detect TB in severely ill PLHIV and can id...

Descripción completa

Detalles Bibliográficos
Autores principales: Singhroy, Diane N., MacLean, Emily, Kohli, Mikashmi, Lessem, Erica, Branigan, David, England, Kathleen, Suleiman, Khairunisa, Drain, Paul K., Ruhwald, Morten, Schumacher, Samuel, Denkinger, Claudia M., Waning, Brenda, Van Gemert, Wayne, Pai, Madhukar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059561/
https://www.ncbi.nlm.nih.gov/pubmed/32185366
http://dx.doi.org/10.12688/gatesopenres.13112.2

Ejemplares similares

Ejemplares similares